GREELEY, Colo., March 25, 2026 (GLOBE NEWSWIRE) — JBS today announced financial results for the fourth quarter and full year ended December 31, 2025, which included record net revenue of US$ 86 billion, an increase of 12% compared to 2024. Net income for the full year 2025 grew 13%, reaching US$ 2 billion. The strong performance was driven primarily by Pilgrim’s Pride Corporation, JBS Australia and Seara, all of which delivered significant organic growth and value creation.
The results underscore the resilience of the company’s global multiprotein and multiplatform strategy across diverse market environments. JBS reported adjusted EBITDA under IFRS of US$ 6.8 billion, with an EBITDA margin of 7.9% for the full year.
“Closing 2025 with 15% revenue growth — the highest in our history — demonstrates the strength and resilience of our diversified platform across proteins and geographies,” said Gilberto Tomazoni, Global CEO of JBS. “At the same time, the 15% increase in net income reinforces the consistency of our execution, supporting robust margins and our ability to continue generating growth and value for our shareholders.”
Financial Highlights
Return on equity (ROE) reached 25% over the last 12 months, an increase of 3.2 percentage points compared to 2024. This improvement was supported by stronger operating results, disciplined capital allocation, and a continued focus on shareholder value creation.
Earnings per share (EPS) rose 15% year-over-year to US$ 1.89. Free cash flow for the year totaled US$ 400 million.
Leverage in dollars ended the year at 2.39x, consistent with the company’s long-term target and stable compared to 3Q25. Beside …